Hsbc Holdings PLC Purchases 6,921 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Hsbc Holdings PLC raised its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 29.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,502 shares of the company’s stock after buying an additional 6,921 shares during the quarter. Hsbc Holdings PLC’s holdings in Pediatrix Medical Group were worth $227,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Pediatrix Medical Group by 1.6% in the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock valued at $105,892,000 after acquiring an additional 164,333 shares during the last quarter. Boston Partners boosted its holdings in shares of Pediatrix Medical Group by 34.0% in the 1st quarter. Boston Partners now owns 1,786,434 shares of the company’s stock valued at $17,702,000 after purchasing an additional 453,254 shares in the last quarter. ClariVest Asset Management LLC bought a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at $1,721,000. Tidal Investments LLC acquired a new position in shares of Pediatrix Medical Group during the 1st quarter worth $442,000. Finally, Principal Financial Group Inc. lifted its position in shares of Pediatrix Medical Group by 1.1% during the 1st quarter. Principal Financial Group Inc. now owns 466,487 shares of the company’s stock worth $4,679,000 after buying an additional 5,265 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Up 1.9 %

Shares of NYSE MD opened at $12.13 on Friday. The firm has a 50 day moving average price of $10.37 and a two-hundred day moving average price of $8.96. The stock has a market cap of $1.02 billion, a P/E ratio of -14.27, a price-to-earnings-growth ratio of 1.74 and a beta of 1.56. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $13.01. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.03. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The business had revenue of $504.30 million during the quarter, compared to analyst estimates of $505.49 million. During the same period last year, the company earned $0.37 EPS. Pediatrix Medical Group’s revenue for the quarter was up .7% compared to the same quarter last year. As a group, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.19 EPS for the current year.

Insider Buying and Selling

In other news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the transaction, the director now directly owns 30,805 shares of the company’s stock, valued at approximately $343,783.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO James D. Swift sold 11,100 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the transaction, the chief executive officer now directly owns 170,001 shares of the company’s stock, valued at $1,834,310.79. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Laura A. Linynsky sold 7,000 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the sale, the director now owns 30,805 shares of the company’s stock, valued at approximately $343,783.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock valued at $701,889 over the last ninety days. 2.00% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on MD shares. Deutsche Bank Aktiengesellschaft upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price on the stock in a research report on Friday, June 7th. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. UBS Group increased their price objective on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the company a “neutral” rating in a research note on Friday, August 9th. Jefferies Financial Group raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $8.00 to $14.00 in a research note on Thursday, September 26th. Finally, StockNews.com upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 7th. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $10.30.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.